Cadrenal Therapeutics (CVKD) Q4 2025 Earnings

10NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-2.15
-1.87
-1.59
-1.31

Details

Expected EPS
-1.55
Actual EPS
-1.31
Surprise EPS
0.24
Surprise Percent
+15.48%

Description

Cadrenal Therapeutics (CVKD) has reported earnings of -1.31 per share for Q4 2025.

0 Comments

Share your thoughts